Bimzelx Prior Authorization Policy
Customize your policy alerts
Sign up for Cigna Policy IP0658 alerts
Get alerted when Policy IP0658 changes without checking for updates manually.
Monitor payer policy activity
Prior authorization and medical-necessity criteria for Bimzelx in adults with ankylosing spondylitis, hidradenitis suppurativa, non-radiographic axial spondyloarthritis, plaque psoriasis, or psoriatic arthritis.
Criteria for ankylosing spondylitis and non-radiographic axial spondyloarthritis were added to the policy.
Criteria for psoriatic arthritis and hidradenitis suppurativa were added to the policy.
Plaque psoriasis requirements were added addressing evaluation of suicidal ideation or behavior, depression, and relevant history for initial and ongoing Bimzelx therapy.
The suicidal-risk and depression requirements were revised to state that, according to the prescriber, the patient has been evaluated for risks versus benefits and does not have moderately severe to severe depression.
A 3-month trial or prior intolerance to Otezla, Otezla XR, or Sotyktu was added as an exception to the plaque psoriasis requirement for a trial of one traditional systemic agent.
The plaque psoriasis methotrexate contraindication requirement was revised to specify that, according to the prescriber, the patient has a contraindication to methotrexate.
Icotyde and tofacitinib generics were added to the appendix.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.